Affimed Logo
  • Science and Technology
    • ICE® (innate cell engager) Molecules
    • ROCK® Platform
    • Publications and Posters
  • Pipeline and Clinical Trials
  • About Us
    • Management Board
    • Supervisory Board
    • Scientific Advisory Board
    • Partners
  • News and Events
  • Innately Affimed
  • Investors
    • Webcasts and Corporate Presentation
    • Analyst Coverage
    • Share Information
    • SEC and Financial Reports
    • Corporate Governance Affimed
    • Press Release Distribution
  • Careers
    • Culture
  • Contact
Menu

News and Events

See what’s new at Affimed

News

All categories
Earnings
Press Release
All years
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Affimed Announces Third Quarter 2019 Financial Results and Corporate Update Conference Call on November 19, 2019

November 14, 2019

Affimed Announces Closing of Public Offering of Common Shares and Exercise of Underwriters’ Option to Purchase Additional Shares

November 13, 2019

Affimed Announces Pricing of Public Offering of Common Shares

November 8, 2019

Affimed Announces Proposed Public Offering of Common Shares

November 7, 2019

Affimed Announces FDA Clearance of IND to Commence First-in-Human Phase 1/2a Study of AFM24 for the Treatment of EGFR-Expressing Cancers

November 7, 2019

Affimed Highlights Progress on NK Cell Engager Collaboration with Genentech

November 7, 2019

Affimed Reports Progress on Key Clinical Development Programs

October 15, 2019

Affimed to Participate in Investor Conferences in September

August 28, 2019

Affimed Reports Second Quarter 2019 Financial and Operational Results

August 7, 2019

Affimed Announces Second Quarter 2019 Financial Results and Corporate Update Conference Call on August 7, 2019

July 31, 2019

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28

Events

All
Scientific
Investors

28Mar

Innate Killer Summit

March 28 - 30, 2023 (San Diego, USA)

14Apr

AACR Annual Meeting 2023

April 14 - 19, 2023 (Orlando, Florida)

23Apr

EBMT 49th Annual Meeting

April 23 - 26, 2023 (Paris, France)

WebcastsMore events

Affimed GmbH
Technologiepark
Im Neuenheimer Feld 582
69120 Heidelberg, Germany

Phone: +49 (0)6221-6743-60
Fax: +49 (0)6221 6743-649
email hidden; JavaScript is required

  • Affimed Science and Technology
    • ICE® (innate cell engager) Molecules
    • ROCK® Platform
    • Publications and Posters
  • About Us
    • Management Board
    • Supervisory Board
    • Scientific Advisory Board
    • Partners
  • News and Events
  • Investors
    • Webcasts and Corporate Presentation
    • Analyst Coverage
    • Share Information
    • SEC and Financial Reports
    • Press Release Distribution
    • Corporate Governance
  • Careers
    • Culture

© 2023 Affimed GmbH

  • Data Protection
  • Imprint
  • Contact